Curcumin metabolites contribute to the effect of curcumin on ameliorating insulin sensitivity in high-glucose-induced insulin-resistant HepG2 cells. (15th September 2020)

• Record Type: Journal Article
• Authors: Li, Pan; Ding, Liqin; Cao, Shijie; Feng, Xinchi; Zhang, Qiang; Chen, Yuwei; Zhang, Nan; Qiu, Feng
• Is Part Of: Journal of ethnopharmacology. Volume 259(2020)
• Publication Date: 2020-09-15
• Subjects: Curcumin -- Insulin sensitivity -- Metabolites -- Network pharmacology -- HepG2 cells; Curcumin (Pubchem CID 969516) -- Dihydrocurcumin (Pubchem CID 10429233) -- Tetrahydrocurcumin (Pubchem CID 124072) -- hexahydroxycurcumin (Pubchem CID 129887252) -- Octahydrocurcumin (Pubchem CID 11068834) -- Vanillin (Pubchem CID 1183) -- vanillin acetal (Pubchem CID 5354238); Ethnopharmacology -- Periodicals; Pharmacognosy -- Periodicals; Herbs -- Periodicals; Herbs -- Periodicals; Pharmacognosy -- Periodicals; Pharmacognosie -- Périodiques; Herbes -- Périodiques; 615.1
• DOI: 10.1016/j.jep.2020.113015
• Languages: English
• ISSNs: 0378-8741

Abstract

Abstract: Ethnopharmacological evidence: Curcumin (CUR) is the active ingredient of Traditional Chinese Medicine turmeric ( Curcuma longa L.), which has been used for treatment of diabetes in Ayurveda and China. CUR exerts potent anti-insulin-resistant effects in various cell lines. However, previous studies indicated CUR was metabolized extensively in vivo and massively degraded in a medium alkaline buffer solution. The real active component of the anti-insulin-resistant activity of CUR in vitro is not clear. Aim of the study: Our study identified the functional contribution of the metabolites of CUR and the related molecular mechanism in improving insulin sensitivity. Materials and methods: HPLC and UPLC-QQQ-MS analyses were used to investigate the stability and metabolism of CUR in HepG2 cells. The effect of the metabolic products of CUR on insulin sensitivity was evaluated in high glucose (HG)-induced insulin-resistant HepG2 cells. A network pharmacology approach was used to examine the potential targets of the metabolites, and Western blotting was performed to verify changes in the targets. Results: CUR was unstable in the cell culture medium, but the prototypes, metabolites and degradation products of CUR coexisted in the HepG2 cell culture experiment. The insulin sensitivity assay demonstrated that CUR and its metabolites enhanced insulin sensitivity in HG-induced insulin-resistant HepG2 cells, but the total degradation products of CUR may not play the major role. Similar to CUR, hexahydrocurcumin (HHC) and octahydrocurcumin (OHC) improved insulin sensitivity by strengthening the PI3K-AKT-GSK3B signal and suppressing the phosphorylation of ERK/JNK in HG-induced insulin-resistant HepG2 cells. Conclusions: Metabolites of CUR played a critical role in counteracting insulin resistance in HG-induced HepG2 cells. CUR exerted anti-insulin resistance effect in HepG2 cells in a multi-component, multi-target, and multi-pathway manner. Graphical abstract: Image 1